Apply until 22nd November! U.S. Market Gateway Hybrid Accelerator for Cell & Gene Therapy-Start-ups - Entering the U.S. Market

8-week Hybrid Program with Experts, Investors, and Mentoring from Industry Leaders.

MED TECH & Biotech-Start-ups.

Entering any new market comes with a variety of opportunities and challenges for growth companies. Statistically, only one in five companies succeeds in expanding to the U.S. market. Our success rate shows that we will double your odds.

To gain fast traction and reliable growth in the U.S., entering companies need both exceptional strategy and execution. If your company is considering or ready to expand to the U.S. market and has demonstrated market traction in your own country or other regions, and/or has sufficient funding for market expansion, this program is for you!

By the end of our eight-week online program with subject matter experts, weekly meetings with industry leader mentors, and in-person session, you will gain the strategy, connections and roadmap for a successful entry to the U.S.

The eight-week online program takes place in Januar and Ferbuary 2024 and will have an on-site program including pitch sessions on 18-19 March 2024 in Philadelphia, USA.

The registration deadline is 22 November:

The program includes 4 modules: U.S. Healthcare and Operations, Legal, Fundraising, and Business Communication.

The accelerator program culminates with the in-person opportunity to pitch to a panel of Angel and VC investors, and visit major local medical centers.